Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacodynamics and Safety of Human Recombinant Luteinising Hormone in Hypogonadotropic Hypogonadal Men

NCT04189133 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria di Modena as lead sponsor.

NCT NCT04189133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04189133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacodynamics and Safety of Human Recombinant Luteinising Hormone in Hypogonadotropic Hypogonadal Men
Lead sponsor
Azienda Ospedaliero-Universitaria di Modena
Phase
Phase 2
Overall status
Unknown status
Start date
January 19, 2022
Completion date
January 18, 2026
Enrollment
32 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acquired hypogonadotropic hypogonadism